A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients

PURPOSE: Amrubicin is one of the most active chemotherapeutic drugs for small cell lung cancer (SCLC). Previous studies reported its effectiveness and severe hematological toxicity. However, the efficacy of amrubicin monotherapy in elderly patients with SCLC has not been described. The objective of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Chemother Pharmacol
Main Authors: Imai, Hisao, Sugiyama, Tomohide, Tamura, Tomohiro, Minemura, Hiroyuki, Kaira, Kyoichi, Kanazawa, Kenya, Yokouchi, Hiroshi, Kasai, Takashi, Kaburagi, Takayuki, Minato, Koichi
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5573757/
https://ncbi.nlm.nih.gov/pubmed/28761968
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-017-3403-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados